MPD: Phenotype measures mapped to MP:0005266, abnormal metabolism

Phenotype measures associated with ontology term
MP:0005266 'abnormal metabolism'

All measures in this list are mapped to the ontology descendants of MP:0005266. None are mapped to MP:0005266 directly.

MP:0002332 abnormal exercise endurance
MP:0005443 abnormal ethanol metabolism
MP:0005584 abnormal enzyme/coenzyme activity
MP:0008961 abnormal basal metabolism
MP:0011577 abnormal lipoprotein lipase activity
MP:0011592 abnormal catalase activity
MP:0011601 abnormal glutathione peroxidase activity
MP:0012623 abnormal acetylcholinesterase activity
MP:0012691 abnormal acetaminophen metabolism
MP:0012692 abnormal fluoxetine metabolism
MP:0012693 abnormal haloperidol metabolism
MP:0012694 abnormal lithium metabolism
MP:0012695 abnormal nicotine metabolism
MP:0012696 abnormal trichloroethene metabolism
MP:0012734 abnormal response to radiation
MP:0012735 abnormal response to exercise
MP:0012780 abnormal phospholipid transfer protein activity
MP:0013275 abnormal xenobiotic metabolism
MP:0020149 abnormal mortality induced by ionizing radiation

This MP term has been mapped to these MPD phenotype measurements to help users find relevant data. It should be noted that MPD measurements typically have a mixture of high-end, low-end and "normal" readings.

Sort/ Pick	Data set	Procedure / Protocol	Treatment	Phenotype Measure / Variable (click to view)	Panel	No. of Strains	Sex	Age	Sample Size (Avg)	Year
Albers1:13	Albers1	protein activity assessment	high-fat diet	phospholipid transfer protein activity (plasma) [µmol/mL/h] PLTP 1913 baseline after 6wks on diet Δchange	inbred	15	both	6-8wks	N=8	1999

Auwerx1:135	Auwerx1	monitoring system	high-fat diet	maximum oxygen consumption, first treadmill training [mL/kg/min] vo2_max_treadmill1 111314 CD HFD	BXD w/par	57	m	23wks	N=4	2016

Auwerx1:137	Auwerx1	treadmill endurance test	high-fat diet	distance traveled, first treadmill training [m] dist_treadmill1 111316 CD HFD	BXD w/par	57	m	23wks	N=4	2016

Auwerx1:141	Auwerx1	running wheel monitoring	high-fat diet	distance traveled, voluntary wheel running test, last 24h [km] dist_wheel 111320 CD HFD	BXD w/par	57	m	23wks	N=4	2016

Auwerx1:143	Auwerx1	running wheel monitoring	high-fat diet	speed (mean rpm), voluntary wheel running test, 24h [n/min] speed_wheel 111322 CD HFD	BXD w/par	36	m	23wks	N=4	2016

Auwerx1:153	Auwerx1	monitoring system	high-fat diet	maximum oxygen consumption, second treadmill training [mL/kg/min] vo2_max_treadmill2 111332 CD HFD	BXD w/par	57	m	25wks	N=4	2016

Auwerx1:155	Auwerx1	treadmill endurance test	high-fat diet	distance traveled, second treadmill training [m] dist_treadmill2 111334 CD HFD	BXD w/par	57	m	25wks	N=4	2016

Auwerx2:119	Auwerx2	treadmill endurance test	(none)	distance traveled, treadmill test [m] dist_treadmill 114647 CD HFD	inbred w/CC8	9	both	19wks	N=4	2021

Bennett3:1	Bennett3	alcohol quantification	ethanol	blood ethanol concentration (BEC) [mg/mL] BEC 37501 first loss of balance (ataxia) first regain of balance second regain of balance	ILSXISS w/par	74	both	8-14wks	N=5	2007

Bennett3:4	Bennett3	alcohol quantification	ethanol	acute functional tolerance to ethanol (BEC2-BEC1) [mg/mL] AFT1 37504	ILSXISS w/par	74	both	8-14wks	N=5	2007

Bennett3:5	Bennett3	alcohol quantification	ethanol	acute functional tolerance to ethanol (BEC2-BEC0) [mg/mL] AFT2 37505	ILSXISS w/par	74	both	8-14wks	N=5	2007

Chesler6:7	Chesler6	alcohol quantification	ethanol	blood ethanol concentration at return of righting reflex [mg/mL] LORR_BEC 27107	QTL population		both	9-34wks	N=186	2012

Clemens1:1	Clemens1	health assessment	ultraviolet light	UV-induced immunosuppression of contact hypersensitivity [%] suppression 10601	QTL population		both	9-30wks	N=67	2000

Crabbe4:11	Crabbe4	alcohol quantification	ethanol	blood ethanol concentration (BEC), 35 min post-injection, dowel (15.8 mm) test [mg/mL] BEC_dowel15_8 19111	inbred	8	both	12-16wks	N=3	2003

Crabbe4:12	Crabbe4	alcohol quantification	ethanol	blood ethanol concentration [mg/mL] BEC 19112 time after ethanol: 30min 60min 105min 150min	inbred	21	both	7-12wks	N=6	2003

Donahue9:11	Donahue9	metabolic panel	(none)	lipase (serum LIP) [U/L] LIP 41811	B6.PWD consomic w/par	25	both	11wks	N=8	2011

GMC09:41	GMC09	monitoring system	(none)	mean heat production, 21 h test, 15 min bins [kJ/h] heat_mean 55841	inbred w/CC8	8	both	12-13wks	N=17	2018

Gould1:5	Gould1	drug and metabolite quantification	lithium	serum lithium concentration [mmol/L] blood_lithium 37405 lithium dose [mg/kg]: 200 300 400	inbred	11	m	7-8wks	N=8	2011

Gould1:8	Gould1	drug and metabolite quantification	lithium	brain lithium concentration [mmol/L] brain_lithium 37408 lithium dose [mg/kg]: 200 300 400	inbred	11	m	7-8wks	N=8	2011

Gould2:1	Gould2	drug and metabolite quantification	nicotine	plasma nicotine [ng/mL] nicotine 47101 acute 0.09mg dose chronic 6.3mg dose	inbred	8	m	8-12wks	N=10	2011

Filter Table Results